H7N9

H7N9 refers to avian influenza A(H7N9), a viral influenza subtype identified in the supplied disease metadata and discussed in the literature as an avian influenza virus of pandemic concern ^[1][3]. Influenza A viruses are described as affecting both humans and animals, and as emerging from zoonotic reservoirs in aquatic birds and bats; however, the sources do not provide H7N9-specific etiologic detail beyond its classification as an avian influenza A subtype ^[4].

The provided sources do not supply a detailed H7N9 symptom profile, severity pattern, incubation period, or complication list, so source-backed clinical characterization is limited ^[2][5]. More generally, influenza is described as an acute respiratory disease in mammals and domestic poultry, but this statement is not H7N9-specific and should be read as contextual background rather than a direct disease description for this subtype ^[4]. Available material indicates that H7N9 has been associated with human infection, but not the clinical course of individual cases ^[6].

The sources describe H7N9 as an avian influenza virus of pandemic concern because of its global spread and sporadic human infections ^[1]. One review notes that H7N9 human infections emerged in 2013 and that China nearly eliminated pervasive H7N9 viruses after adopting a cull-plus-vaccination strategy, but the snippets do not provide incidence trends, current geographic distribution, or case counts specific to H7N9 alone ^[4][6]. More broadly, H7 and H5 subtype avian influenza viruses together have caused 2,634 human cases worldwide and more than 1,000 deaths, yet this aggregate statistic is not attributable to H7N9 alone ^[6].

The provided sources support zoonotic transmission as the primary pathway for human influenza outbreaks and identify avian species as an important source for such spillover ^[1]. They also place influenza within zoonotic reservoirs in aquatic birds and bats, but they do not specify the exact H7N9 exposure mechanisms, settings, or persistence in the environment ^[4].

The sources do not identify H7N9-specific high-risk groups, occupations, age strata, or comorbidity patterns, so source-backed risk-group detail is not yet available ^[2]. The only supported exposure context is contact with avian reservoirs or avian influenza activity, which suggests that people with relevant animal exposure may be of interest in surveillance, but the provided material does not specify which groups are most affected ^[1][4].

Vaccination is identified in the sources as the most effective strategy for influenza prevention and control in humans, although vaccine efficacy varies across strains ^[1]. For avian influenza control more broadly, the literature mentions culling and cull-plus-vaccination strategies, and notes that China used the latter approach in relation to H7N9, but the snippets do not provide an H7N9-specific prevention schedule or formal public-health recommendation set ^[6]. Source-backed detail on personal protective measures is not yet available ^[2].

In surveillance settings, H7N9 should be interpreted as a zoonotic avian influenza subtype with pandemic concern and a history of sporadic human infection ^[1]. The available sources support monitoring of avian and human influenza activity together, particularly where poultry outbreaks and human spillover occur, but they do not provide a disease-specific case definition or threshold for notification ^[4][6]. Accordingly, current page-level surveillance interpretation should remain conservative and avoid inferring local burden or transmission intensity from the snippets alone ^[3].

1. 1 Cargnin Faccin F et al. Pandemic preparedness through vaccine development for avian influenza viruses. Hum Vaccin Immunother. 2024 Dec 31. PMID: 38807261. doi: 10.1080/21645515.2024.2347019. PubMed: https://pubmed.ncbi.nlm.nih.gov/38807261/
2. 2 H7N9 flu. BMC Infectious Diseases. 2014. doi: 10.1186/1471-2334-14-s2-s21. DOI: https://doi.org/10.1186/1471-2334-14-s2-s21
3. 3 Avian Influenza H7N9 Virus. Influenza: Current Research. 2016. doi: 10.21775/9781910190432.08. DOI: https://doi.org/10.21775/9781910190432.08
4. 4 Webster RG et al. Continuing challenges in influenza. Ann N Y Acad Sci. 2014 Sep. PMID: 24891213. doi: 10.1111/nyas.12462. PubMed: https://pubmed.ncbi.nlm.nih.gov/24891213/
5. 5 Shi J et al. Alarming situation of emerging H5 and H7 avian influenza and effective control strategies. Emerg Microbes Infect. 2023 Dec. PMID: 36458831. doi: 10.1080/22221751.2022.2155072. PubMed: https://pubmed.ncbi.nlm.nih.gov/36458831/
6. 6 禽流感H7N9传播模型的动力学分析. 应用数学和力学. 2019. doi: 10.21656/1000-0887.390175. DOI: https://doi.org/10.21656/1000-0887.390175

ICD-10

J09

ICD-11

1E30.0

Total cases

1K

Total deaths

565

Peak month

2017-01

Coverage

2 reporting countries · 2013-11-01 → 2026-06-20